Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease

Cell

Volumn 84, Issue 3, 1996, Pages 443-450

  Durbin, Joan E ^a   Hackenmiller, Renée ^b   Simon, M Celeste ^b   Levy, David E ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTOKINE; GAMMA INTERFERON; LEUKEMIA INHIBITORY FACTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CONTROLLED STUDY; DISEASE PREDISPOSITION; EMBRYO CELL; FAILURE TO THRIVE; GENE DISRUPTION; GENE TARGETING; GENETIC TRANSCRIPTION; IMMUNE DEFICIENCY; MOUSE; NONHUMAN; OPPORTUNISTIC INFECTION; PRIORITY JOURNAL; STEM CELL; VESICULAR STOMATITIS VIRUS; VIRUS INFECTION;

ANIMALIA; VESICULAR STOMATITIS VIRUS;

EID: 0030024563     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)81289-1     Document Type: Article

References (62)

1. Bhat, G.J., Thekkumkara, T.J., Thomas, W.G., Conrad, K.M., and Baker, K.M. (1994). Angiotensin II stimulates cis-inducing factor-like DNA binding activity: evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein. J. Biol. Chem. 269, 31443-31449.
2. Bluyssen, H.A.R., Muzaffar, R., Vlieststra, R.J., van der Made, A.C.J., Leung, S., Stark, G.R., Kerr, I.M., Trapman, J., and Levy, D.E. (1995). Combinatorial association and abundance of interferon gene factor 3 components dictate the selectivity of interferon responses. Proc. Natl. Acad. Sci. USA 92, 5645-5649.
3. Boulton, T.G., Zhong, Z., Wen, Z., Darnell, J.E., Stahl, N., and Yancopoulos, G.D. (1995). STAT3 activation by cytokines utilizing gp130 and related transducers involves a secondary modification requiring an NT-sensitive kinase. Proc. Natl. Acad. Sci. USA 92, 6915-6919.
4. Bradley, A., Evans, M., Kaufman, M.H., and Robertson, E. (1984). Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature 309, 255-256.
5. Campbell, G.S., Meyer, D.J., Raz, R., Levy, D.E., Schwartz, J., and Carter-Su, C. (1995). Activation of acute phase response factor (APRF)/Stat3 transcription factor by growth hormone. J. Biol. Chem. 270, 3974-3979.
6. Compton, S.R., Barthold, S.W., and Smith, A.L. (1993). The cellular and molecular pathogenesis of coronaviruses. Lab. Animal Sci. 43, 15-28.
7. Darnell, J.E., Kerr, I.M., and Stark, G.R. (1994). JAK-STAT pathways and transcriptional activation in response to IFNs and other extracellular proteins. Science 264, 1415-1421.
8. David, M., Petricoin, E.F., Igarashi, K.-I., Feldman, G.M., Finbloom, D.S., and Larner, A.C. (1994). Prolactin activates the interferon-regulated p91 transcription factor and the Jak2 kinase by tyrosine phosphorylatlon. Proc. Natl. Acad. Sci. USA 91, 7174-7178.
9. Dignam, J.D., Lebovitz, R.M., and Roeder, R.G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucl. Acids Res. 11, 1475-1489.
10. Fujita, T., Sakakibara, J., Sudo, Y., Miyamoto, M., Kimura, Y., and Taniguchi, T. (1988). Evidence for a nuclearfactor(s), IRF-1, mediating induction and silencing properties to human IFN-β gene regulatory elements. EMBO J. 7, 3397-3405.
11. Fujita, T., Kimura, Y., Miyamoto, M., Barsoumian, E.L., and Taniguchi, T. (1989). Induction of endogenous IFN-α and IFN-β genes by a regulatory transcription factor, IRF-1. Nature 337, 270-272.
12. Greenlund, A.C., Farrar, M.A., Viviano, B.L., and Schreiber, R.D. (1994). Ligand-induced IFNγ receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J. 13, 1591-1600.
13. Guschin, D., Rogers, N., Briscoe, J., Wirthuhn, B., Watling, D., Horn, F., Pellegrini, S., Yasukawa, K., Heinrich, P., Stark, G.R., Ihle, J.N., and Kerr, I.M. (1995). A major role for the protein tyrosine kinase JAK1 in the JAK/STAT signal transduction pathway in response to interleukin-6. EMBO J. 14, 1421-1429.
14. Havell, E.A., and Vilcek, J. (1972). Production of high-titered interferon in cultures of human diploid cells. Antimicrob. Agents Chem. 2, 476-484.
15. Heim, M.H., Kerr, I.M., Stark, G.S., and Darnell, J.E. (1995). Contribution of STAT SH2 groups to specific interferon signaling by the JAK-STAT pathway. Science 267, 1347-1349.
16. Horvath, C.M., Wen, Z., and Darnell, J.E. (1995). A Stat protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev. 9, 984-994.
17. Huang, S., Hendriks, W., Althage, A., Hemmi, S., Bluethmann, H., Kamijo, R., Vilcek, J., Zinkernagel, R.M., and Aguet, M. (1993). Immune response in mice that lack the interferon-γ receptor. Science 259, 1742-1745.
18. Hume, D. A., and Favot, P. (1995). Is the osteopetrotic (op/op mutant) mouse completely deficient in expression of macrophage colony-stimulating factor? J. Interferon Cyt. Res. 15, 279-284.
19. Ihle, J.N., and Kerr, I.M. (1995). Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11, 69-74.
20. Kawakami, T., Matsumoto, M., Sato, M., Harada, H., Taniguchi, T., and Kitagawa, M. (1995). Possible involvement of the transcription factor ISGF3γ in virus-induced expression of the IFN-β gene. FEBS Lett. 358, 225-229.
21. Lamb, P., Seidel, H.M., Haslam, J., Milocco, L., Kessler, L.V., Stein, R. B., and Rosen, J. (1995). STAT protein complexes activated by interferon-γ and gp130 signaling molecules differ in their sequence preferences and transcriptional induction properties. Nucl. Acids Res. 23, 3283-3289.
22. Larner, A.C., David, M., Feldman, G.M., Igarashi, K., Hackett, R.H., Webb, D.S.A., Sweitzer, S.M., Petricoin, E.F., and Finbloom, D.S. (1993). Tyrosine phosphorylation of DNA binding proteins by multiple cytokines. Science 261, 1730-1733.
23. Leaman, D.W., Pisharody, S., Flickinger, T.W., Commane, M.A., Schlessinger, J., Kerr, I.M., Levy, D.E., and Stark, G.M. (1996). Roles of JAKs in activation of STATs and stimulation of c-fos expression by epidermal growth factor. Mol. Cell. Biol. 16, 369-375.
24. Leveen, P., Pekny, M., Gebre, M.S., Swolin, B., Larsson, E., and Betsholtz, C. (1994). Mice deficient for PDGF B show renal, cardiovascular, and hematological abnormalities. Genes Dev. 8, 1875-1887.
25. Levy, D.E. (1995). Interferon induction of gene expression through the Jak-Stat pathway. Semin. Virol. 6, 181-189.
26. Levy, D.E., and Darnell, J.E. (1990). Interferon-dependent transcriptional activation: signal transduction without second messenger involvement? New Biol. 2, 923-928.
27. Lord, K.A., Hoffman, L.B., and Liebermann, D.A. (1990). Complexity of the immediate early response of myeloid cells to terminal differentiation and growth arrest includes ICAM-1, jun-B and histone variants. Oncogene 5, 387-396.
28. Marrero, M.B., Schieffer, B., Paxton, W.G., Heerdt, L., Berk, B.C., Delafontaine, P., and Bernstein, K.E. (1995). Direct stimulation of JAK/STAT pathway by the angiotensin II AT1 receptor. Nature 375, 247-250.
29. Mortensen, R.M., Conner, D.A., Chao, S., Geisterfer-Lowrance, A.A.T., and Seidman, J.G. (1992). Production of homozygous mutant ES cells with a single targeting construct. Mol. Cell. Biol. 12, 2391-2395.
30. Müller, M., Briscoe, J., Laxton, C., Buschlin, D., Ziemiecki, A., Silvennoinen, O., Harpur, A.G., Barbieri, G., Witthuhn, B.A., Schindler, C., Pellegrini, S., Wilks, A.F., Ihle, J.N., Stark, G.R., and Kerr, I.M. (1993a). The proteintyrosine klnase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature 366, 129-135.
31. Müller, M., Laxton, C., Briscoe, J., Schindler, C., Improta, T., Darnell, J.E., Stark, G.R., and Kerr, I.M. (1993b). Complementation of a mutant cell line: central role of the 91 kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12, 4221-4228.
32. Müller, U., Steinhoff, U., Reis, L.F.L., Hemmi, S., Pavlovic, J., Zinkernagel, R.M., and Aguet, M. (1994). Functional role of type I and type II interferons in antiviral defense. Science 264, 1918-1921.
33. Pine, R., Decker, T., Kessler, D.S., Levy, D.E., and Darnell, J.E. (1990). Purification and cloning of interferon-stimulated-gene factor 2 (ISGF-2): ISGF2 (IRF-1) can bind to the promoters of both β interferon- and interferon-stimulated genes but is not a primary transcriptional activator of either. Mol. Cell. Biol. 10, 2448-2457.
34. Pine, R., Canova, A., and Schindler, C. (1994). Tyrosine phosphorylated p91 binds to a single element in the ISGF2/IRF1 promoter to mediate induction by IFNα and IFNγ, and is likely to autoregulate the p91 gene. EMBO J. 13, 158-167.
35. Raz, R., Durbin, J.E., and Levy, D.E. (1994). Acute phase response factor and additional members of the interferon-stimulated gene factor 3 family integrate diverse signals from cytokines, interferons, and growth factors. J. Biol. Chem. 269, 24391-24395.
36. Ruff-Jamison, S., Chen, K., and Cohen, S. (1993). Induction of EGF and interferon-γ of tyrosine phosphorylated DNA binding proteins in mouse liver nuclei. Science 261, 1733-1736.
37. Sadowski, H.B., Shuai, K., Darnell, J.E., and Gilman, M.Z. (1993). A common nuclear signal transduction pathway activated by growth factor and cytokine receptors. Science 261, 1739-1744.
38. Schijns, V.E.C.J., Haagmans, B.L., Rijke, E.O., Huang, S., Aguet, M., and Horzinek, M.C. (1994). IFN-γ receptor-deficient mice generate antiviral Th1-characteristic cytokine profiles but altered antibody responses. J. Immunol. 153, 2029-2037.
39. Schindler, C., and Darnell, J.E. (1995). Transcriptional responses to polypeptide ligands: the Jak-Stat pathway. Annu. Rev. Biochem. 64, 621-651.
40. Schindler, C., Shuai, K., Prezioso, V.R., and Darnell, J.E. (1992). Interferon-dependent tyrosine phosphorylation of a latent cytoplasmic transcription factor. Science 257, 809-813.
41. Schindler, U., Wu, P., Rothe, M., Brasseur, M., and McKnight, S.L. (1995). Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2, 689-697.
42. Seidel, H.M., Milocco, L.H., Lamb, P., Darnell, J.E., Stein, R.B., and Rosen, J. (1995). Spacing of palindromic half sites as a determinant of selective STAT DNA binding and transcriptional activity. Proc. Natl. Acad. Sci. USA 92, 3041-3045.
43. Shuai, K., Horvath, C.M., Huang, L.H.T., Qureshi, S.A., Cowburn, D., and Darnell, J.E. (1994). Interferon activation of the transcription factor Stat91 involves dimerization through SH2-phosphotyrosyl peptide interactions. Cell 76, 821-828.
44. Sibilia, M., and Wagner, E.F. (1995). Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269, 234-238.
45. Silvennoinen, O., Ihle, J.N., Schlessinger, J., and Levy, D.E. (1993a). Interferon-induced nuclear signaling by JAK protein tyrosine kinases. Nature 366, 583-585.
46. Silvennoinen, O., Schindler, C., Schlessinger, J., and Levy, D.E. (1993b). Ras-independent signal transduction in response to growth factors and cytokines by tyrosine phosphorylation of a common transcription factor. Science 261, 1736-1739.
47. - mouse embryonic stem cells. Nature Genet. 1, 92-98.
48. Sims, S.H., Cha, Y., Romine, M.F., Gao, P.Q., Gottlieb, K., and Deisseroth, A.B. (1993). A novel interferon-inducible domain: structural and functional analysis of the human interferon regulatory factor 1 gene promoter. Mol. Cell. Biol. 13, 690-702.
49. Smith, A.L., Barthold, S.W., DeSouza, M.S., and Bottomly, K. (1991). The role of interferon in infection of susceptible mice with murine coronavirus MHV-JHM. Arch. Virol. 121, 89-100.
50. Stahl, N., Farruggella, T.J., Boulton, T.G., Zhong, Z., Darnell, J.E., and Yancopoulos, G.D. (1995). Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267, 1349-1353.
51. Steinhoff, U., Müller, U., Schertler, A., Hengartner, H., Aguet, M., and Zinkernagel, R.M. (1995). Antiviral protection by vesicular stomatitis virus-specific antibodies in α/β interferon receptor-deficient mice. J. Virol. 69, 2153-2158.
52. Threadgill, D.W., Dlugosz, A.A., Hansen, L.A., Tennenbaum, T., Lichti, U., Yee, D., LaMantia, C., Mourton, T., Herrup, K., Harris, R.C., et al. (1995). Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269, 230-234.
53. Todaro, G.J., and Green, H. (1963). Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines. J. Cell Biol. 17, 299-313.
54. Tybulewicz, V.J., Crawford, C.E., Jackson, P.K., Bronson, R.T., and Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-ab/proto-oncogene. Cell 65, 1153-1163.
55. van den Broek, M.F., Müller, U., Huang, S., Aguet, M., and Zinkernagel, R.M. (1995). Antiviral defense in mice lacking both α/β and γ Interferon receptors. J. Virol. 69, 4792-4796.
56. Veals, S.A., Santa Maria, T., and Levy, D.E. (1993). Two domains of ISGF3γ that mediate protein-DNA and protein-protein interaction during transcription factor assembly contribute to DNA-binding specificity. Mol. Cell. Biol. 13, 196-206.
57. Waksman, G., Kominos, D., Robertson, S.C., Pant, N., Baltimore, D., Birge, R.B., Cowburn, D., Hanafusa, H., Mayer, B.J., Overduin, M., et al. (1992). Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature 358, 646-653.
58. Watling, D., Guschin, D., Müller, M., Silvennoinen, O., Witthuhn, B.A., Ihle, J.N., Stark, G.R., and Kerr, I.M. (1993). Complementation of a mutant cell line defective in the interferon-γ signal transduction pathway by the protein tyrosine kinase JAK2. Nature 366, 166-170.
59. Wiktor-Jedrzejczak, W., Bartocci, A., Ferrante, A.W., Ahmed-Ansari, A., Sell, K.W., Pollard, J.W., and Stanley, E.R. (1990). Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc. Natl. Acad. Sci. USA 87, 4828-4832.
60. Wurst, W., and Joyner, A.L. (1993). Production of targeted embryonic stem cell clones. In Gene Targeting, D. Rickwood and B.D. Hames, eds. (Oxford: Oxford University Press), pp. 33-61.
61. Yoshida, H., Hayashi, S., Kunisada, T., Ogawa, M., Nishikawa, S., Okumura, H., Sudo, T., Schultz, D., and Nishikawa, S. (1990). The murine mutation osteopetrosis is in the coding region of the macrophage colony-stimulating factor gene. Nature 345, 442-445.
62. Zhang, X., Blenis, J., Li, H.C., Schindler, C., and Chen, K.S. (1995). Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267, 1990-1994.